Top Banner
1 พพพพพพพพพพพพพ พพ พ.พ.2510 พพพ พพพพ พพพพพพพพพพพพพพ
89

พรบ.ยา 2510

Sep 04, 2015

Download

Documents

oreovate

dd
Welcome message from author
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Transcript
  • ..2510

  • ... .. 2510

  • - - - -

  • - - -

  • - - -

  • ()- - -

  • - -

  • - - - - ,corticosteriod, clofibrate, dipyrone, ARVs ,cisapride, misoprostol ,neuromuscular blocking agents, ...

  • - - - , , ARVS , ABO, ..- : , Penicillin V potassium dry syrup 5 . . 2

  • 1.Dextromethorphan HBr 12 mg. 4 10 2.HCTZ 50 mg. 4 10 3.Ethinylestradiol 0.03-0.05 mg or Mestranol 0.03-0.05 mg. + Norgestrel 0.25-0.5 mg.or Levonorgestrel 0.125-0.25 mgor Norethisterone1.0-2.5 mgor Lynestrenol 1.0-2.5 mg

  • ()4. CPM 2 mg 4 20 5.Paracetamol 300 - 500 mg + CPM 1-2 mg 4 10 6. Aminophylline 100 mg 4 7. Theophylline anhydrous 60-150 mg+ Ephedrine HCL15-50 mg 4 8. Co-trimoxazole 400+80 mg 4 10 9. Phthalysulphathiazole 500 mg 4 20

  • 11. Mebendazole 100 mg or Mebendazole 500 mg per tablet 6 10 12.Dimenhydrinate 50 mg. 4 10 13. Sulphadoxine 500 mg + Pyrimethamine 25 mg 4 10 ()10. Penicillin V Potassium equivalent to Penicillin V 200,000 units 60 ml

  • -, , , , , , , , , , ,

  • 1. 2. 3. 4.

  • - - - - - -

  • - 30 - - ()

  • 4 1. 2. 3. 4.

  • (. 15) 6 (1) (2) (3) (4) (5) (6)

  • (1) (2) (3)

  • (1) (2) (3) (4)

  • (5) (6) () () () () (7)

  • (8) (9) ()

  • (.25) (1) (2) (3) (4) (5) (6) (7)

  • (. 26)(1) (2) (3) (4) (5) (6) (7) (8) -

  • 26 (4) 26

  • 26

  • ( 27) (1) (2) (3) (4) (5) (6)

  • (1) (2) (3) (4) (5) (6) (7)

  • (8) (9) (10) (11) 76 (7) (8) , (1) (4) (11)

  • ( 46) ( 47) (1.) (2.) 76 (1)

  • (2 ) (3.)(4.)

  • 4 1. 2. 3. 4.

  • 1) 2) 3)

  • 1. (. ..)2. (. .. )3. (. ..)

  • 48 () 68 69 70 (4) (5) (6)

  • ( 57)1) 2 2) 3) 4) 5)

  • 6) ( 54 ) [ 25 (.. 2537) ] ()

  • ( 58)1) 2 2) 3)

  • ( 59) (1) 2 (2)

  • (3) (4) (5) (56) ()

  • (1) (2) (3) (4) (5) (6) (7) (8) (9) (10)

  • .. 2510 ( 3) .. 2522 ( 5) .. 2530 4

  • ...( 79)

  • ( 79 )1) 2) 3)

  • 1) 2 ) ) 2) 3 ) ) )

  • ( 79) ) )

  • 2 1. 2.

  • 3 8.1.1 8.1.2 8.1.3

  • ( 83)(1) (2) (3) (4) (5)

  • (New Drugs) (1) (New chemical entities) (New derivatives) (2) (New Indication) (3) / (New Combination) (4) (New delivery) (Bioavailability)

  • 8.2.1 (Original products)8.2.2 (Generic products)

  • (Original products) 2 1. 2.

  • Original products (Original products) (Condition Approval)

  • Original products (1) (Protocol) 2 (2)

  • (3) (Unconditional Approval)

  • (Generic products) 3 1. (Bioequivalence)

  • 2. 8.1.1 3.

  • 1. 2.

  • 3. 4. 5. 6.

  • 3 1. 2. 3.

  • 1. 2. 3.

  • 3.1 3.2 3.3 3.4 3.5 3.6

  • 2 ) ) 83

  • 2 1. 2.

  • - - - - ()

  • 1. 2. 3. 4. (Disintegration time)5. (Dissolution time)6. 7.

  • 1. 2. 3. 2 1 1

  • - - Accreditation overseas suppliers FDA certificate of free sale-

  • - 1. 2. 3. 4.

  • 11.

    ( 72)

  • (1) (2) (3) (4) (5)

  • (1) (2) 86

  • (1) (2)

  • ( 85 )

  • 12. ( 88)(1) (2) (3)

  • (4) (5) (6) (7) (8) 77

  • (9) (.89)(10) (.90) ( 88 ) (1) (4) (5) (6) (7) (8)

  • 88 (1) ((2)

  • - - - - - - -

  • - - - - - ()

  • 1. - - - - - - - -

  • 2. - - - - 3. -